title: Chronic invasive sinus aspergillosis in immunocompetent hosts: a geographic comparison.
abstract: OBJECTIVE
  To investigate potential differences in clinical presentation, histopathology, and outcomes of chronic invasive sinus aspergillosis (CISA) based on geographic region and species of Aspergillus isolated.
  
  
  METHODS
  A retrospective analysis of published cases of CISA with a comparison of North American and worldwide cases comprised a systematic search of the English language literature. Thirty-four articles were identified detailing 15 North American and 76 global cases of CISA with cranio-cerebral extension in clinically immunocompetent patients.
  
  
  RESULTS
  North American patients with CISA were older, had a more rapidly progressive course, and appeared to have higher rates of treatment failure and mortality. Anatomic distribution and presenting symptoms were similar between the two groups. North American cases were mostly due to A. fumigatus, while A. flavus was the predominant pathogen worldwide. While granulomatous inflammation was a rare observation in North American cases, it was seen in the majority of cases worldwide. CISA due to A. fumigatus was encountered in older adults, was associated with a chronic inflammatory response, an accelerated clinical course, and a trend toward treatment failure and higher mortality. Patients with A. flavus were younger, demonstrated granulomatous inflammation, and pursued an indolent, clinically responsive course.
  
  
  CONCLUSIONS
  Observed differences in clinical presentation, histopathology, and outcome might involve a complex interplay between the human host, Aspergillus species, and local climatic conditions.
authors.affiliation: Department of Internal Medicine, Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA. webb.brandon@mayo.edu
authors.forename: Brandon J
authors.initials: BJ
authors.lastname: Webb
authors.forename: Holenarasipur R
authors.initials: HR
authors.lastname: Vikram
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001228:Aspergillosis / Q000453:epidemiology* / Q000382:microbiology* / Q000401:mortality / Q000473:pathology; D001231:Aspergillus flavus / Q000302:isolation & purification*; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D005260:Female; D005843:Geography; D006651:Histocytochemistry; D006801:Humans; D008297:Male; D008875:Middle Aged; D009656:North America / Q000453:epidemiology; D010254:Paranasal Sinus Diseases / Q000453:epidemiology* / Q000382:microbiology* / Q000401:mortality / Q000473:pathology; D012189:Retrospective Studies; D017211:Treatment Failure; D055815:Young Adult